ARRDC3 and breast carcinoma: Importantly, the sensitivity of breast cancer cells to SINE compounds may depend not only on ARRDC3 protein levels, but also on the availability of ARRDC3 downstream substrates and their phosphorylation status as ARRDC3 only interacts with phosphorylated form of their substrates [17].